Abstract | BACKGROUND: Inhibition of AKT with MK-2206 has demonstrated synergism with anticancer agents. This phase 1 study assessed the MTD, DLTs, PK, and efficacy of MK-2206 in combination with cytotoxic and targeted therapies. METHODS: RESULTS: MTD of MK-2206 (N = 72) was 45 mg QOD or 200 mg Q3W (arm 1); MAD was 200 mg Q3W (arm 2) and 135 mg QW (arm 3). DLTs included skin rash (arms 1, 3), febrile neutropenia (QOD, arms 1, 2), tinnitus (Q3W, arm 2), and stomatitis (QOD, arm 3). Common drug-related toxicities included fatigue (68%), nausea (49%), and rash (47%). Two patients with squamous cell carcinoma of the head and neck (arm 1; Q3W) demonstrated a complete and partial response (PR); additional PRs were observed in patients (1 each) with melanoma, endometrial, neuroendocrine prostate, NSCLC, and cervical cancers. Six patients had stable disease ≥6 months. CONCLUSION:
|
Authors | L Rhoda Molife, Li Yan, Joanna Vitfell-Rasmussen, Adriane M Zernhelt, Daniel M Sullivan, Philippe A Cassier, Eric Chen, Andrea Biondo, Ernestina Tetteh, Lillian L Siu, Amita Patnaik, Kyriakos P Papadopoulos, Johann S de Bono, Anthony W Tolcher, Susan Minton |
Journal | Journal of hematology & oncology
(J Hematol Oncol)
Vol. 7
Pg. 1
(Jan 03 2014)
ISSN: 1756-8722 [Electronic] England |
PMID | 24387695
(Publication Type: Clinical Trial, Phase I, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Heterocyclic Compounds, 3-Ring
- MK 2206
- Quinazolines
- Taxoids
- Docetaxel
- Carboplatin
- Erlotinib Hydrochloride
- Proto-Oncogene Proteins c-akt
- Paclitaxel
|
Topics |
- Administration, Oral
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Area Under Curve
- Carboplatin
(administration & dosage, adverse effects)
- Docetaxel
- Dose-Response Relationship, Drug
- Erlotinib Hydrochloride
- Exanthema
(chemically induced)
- Fatigue
(chemically induced)
- Febrile Neutropenia
(chemically induced)
- Female
- Heterocyclic Compounds, 3-Ring
(administration & dosage, adverse effects, pharmacokinetics)
- Humans
- Male
- Middle Aged
- Nausea
(chemically induced)
- Neoplasms
(classification, drug therapy, metabolism)
- Paclitaxel
(administration & dosage, adverse effects)
- Proto-Oncogene Proteins c-akt
(antagonists & inhibitors, metabolism)
- Quinazolines
(administration & dosage, adverse effects)
- Stomatitis
(chemically induced)
- Taxoids
(administration & dosage, adverse effects)
- Tinnitus
(chemically induced)
- Treatment Outcome
- Young Adult
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|